Inhibition selectivity of grapefruit juice components on human cytochromes P450

Archives of Biochemistry and Biophysics

Volumn 378, Issue 2, 2000, Pages 356-363

  Tassaneeyakul, Wichittra ^a,b   Guo, Lian Qing ^b   Fukuda, Katsuyuki ^c   Ohta, Tomihisa ^d   Yamazoe, Yasushi ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b TOHOKU UNIVERSITY   (Japan)

^c MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

Author keywords

CYP3A4; Cytochromes P450 inhibition; Drug grapefruit juice interaction; Furanocoumarins

Indexed keywords

ACETIC ACID ETHYL ESTER; BENZOPYRAN DERIVATIVE; BERGAMOT OIL; CHLORZOXAZONE; CYTOCHROME P450 2C9; CYTOCHROME P450 3A4; CYTOCHROME P450 INHIBITOR; CYTOCHROME P450 ISOENZYME; DEBRISOQUINE 4 HYDROXYLASE; DEXTROMETHORPHAN; FUROCOUMARIN; NIFEDIPINE; OMEPRAZOLE SULFONE; PHENACETIN; PHENACETIN O DEETHYLASE; SESQUITERPENE DERIVATIVE; TOLBUTAMIDE;

ARTICLE; CONTROLLED STUDY; DRUG HYDROXYLATION; DRUG OXIDATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME SPECIFICITY; FRUIT JUICE; GRAPE; HUMAN; HUMAN TISSUE; LIVER MICROSOME; PRIORITY JOURNAL;

CITRUS X PARADISI; OXY; VITIS SP.;

EID: 0034660149     PISSN: 00039861     EISSN: None     Source Type: Journal    
DOI: 10.1006/abbi.2000.1835     Document Type: Article

References (40)

1. Bailey D. G., Edgar B., Spence J. D., Munoz C., Arnold J. M. Clin. Pharmacol. Ther. 47:1990;180.
2. Soons P. A., Vogels B. A., Roosemalen M. C., Schoemaker H. C., Uchida E., Edgar B., Lundahl J., Cohen A. F., Breimer D. D. Clin. Pharmacol. Ther. 50:1991;394-403.
3. Bailey D. G., Arnold J. M., Munoz C., Spence J. D. Clin. Pharmacol. Ther. 53:1993;637-642.
4. Schubert W., Cullberg G., Edgar B., Hedner T. Maturitas. 20:1994;155-163.
5. Ducharme M. P., Warbasse L. H., Edwards D. J. Clin. Pharmacol. Ther. 57:1995;485-491.
6. Kupferschmidt H. H., Ha H. R., Ziegler W. H., Meier P. J., Krahenbuhl S. Clin. Pharmacol. Ther. 58:1995;20-28.
7. Hukkinen S. K., Varhe A., Olkkola K. T., Neuvonen P. J. Clin. Pharmacol. Ther. 58:1995;127-131.
8. Benton R. E., Honig P. K., Zamani K., Cantilena L. R., Woosley R. L. Clin. Pharmacol. Ther. 59:1996;383-388.
9. Lundahl J., Regardh C. G., Edgar B., Johnsson G. Eur. J. Clin. Pharmacol. 52:1997;139-145.
10. Guengerich F. P. Ortiz de Motellano P. R. Cytochrome P450: Structure, Mechanism, and Biochemistry. 1995;473-536 Plenum, New York and London.
11. Guengerich F. P., Kim D. H. Carcinogenesis. 11:1990;2275-2279.
12. Miniscalco A., Lundahl J., Regardh C. G., Edgar B., Eriksson U. G. J. Pharmacol. Exp. Ther. 261:1992;1195-1199.
13. Bailey D. G., Arnold J. M., Strong H. A., Munoz C., Spence J. D. Clin. Pharmacol. Ther. 54:1993;589-594.
14. Edwards D. J., Bernier S. M. Life Sci. 59:1996;1025-1030.
15. Rashid J., McKinstry C., Renwick A., Dirnhuber M., Waller D., George C. Br. J. Clin. Pharmacol. 36:1993;460-463.
16. Fukuda K., Ohta T., Oshima Y., Ohashi N., Yoshikawa M., Yamazoe Y. Pharmacogenetics. 7:1997;391-396.
17. Schmiedlin-ren P., Edwards D. J., Fitzsimmons M. E., He K., Lown K. S., Woster P. M., Rahman A., Thummel K. E., Fisher J. M., Hollenberg P. F., Watkins P. B. Drug Metab. Dispos. 25:1997;1228-1233.
18. Merkel U., Sigusch H., Hoffmann A. Eur. J. Clin. Pharmacol. 46:1994;175-177.
19. Runkel M., Bourian M., Tegtmeier M., Legrum W. Eur. J. Clin. Pharmacol. 53:1997;265-269.
20. Fuhr U., Klittich K., Staib A. H. Br. J. Clin. Pharmacol. 35:1993;431-436.
21. Maish W. A., Hampton E. M., Whitsett T. L., Shepard J. D., Lovallo W. R. Pharmacotherapy. 16:1996;1046-1052.
22. Fukuda K., Ohta T., Yamazoe Y. Biol. Pharm. Bull. 20:1997;560-564.
23. Yasumori T., Murayama N., Yamazoe Y., Abe A., Nogi Y., Fukasawa T., Kato R. Mol. Pharmacol. 35:1989;443-449.
24. Tassaneeyakul W., Birkett D. J., Veronese M. E., McManus M. E., Tukey R. H., Quattrochi L. C., Gelbion H. V., Miners J. O. J. Pharmacol. Exp. Ther. 265:1993;401-407.
25. Koenigs L. L., Peter R. M., Thompson S. J., Rettie A. E., Trager W. F. Drug Metab. Dispos. 25:1997;1407-1415.
26. Miners J. O., Smith K. J., Robson R. A., McManus M. E., Veronese M. E., Birkett D. J. Biochem. Pharmacol. 37:1988;1137-1144.
27. Ducharme J., Abdullah S., Wainer I. W. J. Chromatogr. B. 678:1996;113-128.
28. Tassaneeyakul W., Veronese M. E., Birkett D. J., Gonzalez F. J., Miners J. O. Biochem. Pharmacol. 46:1993;1975-1981.
29. Andersson T., Miners J. O., Veronese M. E., Tassaneeyakul W., Tassaneeyakul W., Meyer U. A., Birkett D. J. Br. J. Clin. Pharmacol. 36:1993;521-530.
30. Guengerich F. P., Martin M. V., Beaune P. H., Kremers P., Wolf T., Waxman D. J. J. Biol. Chem. 261:1986;5051-5060.
31. Dixon M. Science. 116:1953;329-331.
32. Silverman R. B. Silverman R. B. Chemistry and Enzymology. 1988;3-30 CRC Press, Boca Raton.
33. Yamazaki H., Inoue K., Shaw P. M., Checovich W. J., Guengerich F. P., Shimada T. J. Pharmacol. Exp. Ther. 283:1997;434-442.
34. Edwards D. J., Bellevue F. H., Woster P. M. Drug Metab. Dispos. 24:1996;1287-1290.
35. Lown K. S., Bailey D. G., Fontana R. J., Janardan S. K., Adair C. H., Fortlage L. A., Brown M. B., Guo W., Watkins P. B. J. Clin. Invest. 99:1997;2545-2553.
36. Kunze K. L., Trager W. F. Chem. Res. Toxicol. 6:1993;649-656.
37. Draper A. J., Madan A., Parkinson A. Arch. Biochem. Biophys. 341:1997;47-61.
38. Cai Y., Baer-Dubowska W., Ashwood-Smith M. J., Ceska O., Tachinaba S., DiGiovanni J. Chem. Res. Toxicol. 9:1996;729-736.
39. Bailey D. G., Kreeft J. H., Munoz C., Freeman D. J., Bend J. R. Clin. Pharmacol. Ther. 64:1998;248-256.
40. He K., Iyer K. R., Hayes R. N., Sinz M. W., Woolf T. F., Hollenberg P. F. Chem. Res. Toxicol. 11:1998;252-259.